$SNWV
SANUWAVE Health, Inc. Stock $snwv

$snwv Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000114036123015331 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q1
Revenue	$3.775M	$5.500M	$3.195M
YoY Change	18.15%	29.11%	50.99%
Cost Of Revenue	$1.262M	$1.741M	$889.0K
YoY Change	41.96%	31.1%	-15.73%
Gross Profit	$2.513M	$3.759M	$2.306M
YoY Change	8.98%	28.21%	117.34%
Gross Profit Margin	66.57%	68.35%	72.18%
Selling, General & Admin	$4.171M	$6.511M	$3.856M
YoY Change	8.17%	50.13%	-21.45%
% of Gross Profit	165.98%	173.21%	167.22%
Research & Development	$131.0K	$73.00K	$166.0K
YoY Change	-21.08%	-58.99%	-53.11%
% of Gross Profit	5.21%	1.94%	7.2%
Depreciation & Amortization	$259.0K	$191.0K	$191.0K
YoY Change	35.6%	-28.2%	103.19%
% of Gross Profit	10.31%	5.08%	8.28%
Operating Expenses	$4.491M	$6.775M	$3.644M
YoY Change	23.24%	27.85%	-33.2%
Operating Profit	-$1.978M	-$3.016M	-$1.338M
YoY Change	47.83%	27.42%	-69.55%
Interest Expense	-$11.08M	-$4.329M	$349.0K
YoY Change	-3273.35%	-36.64%	-166.22%
% of Operating Profit
Other Income/Expense, Net	-$11.10M		-$3.085M
YoY Change	259.87%		485.39%
Pretax Income	-$13.08M	-$8.156M	-$4.423M
YoY Change	195.73%	-13.74%	-10.12%
Income Tax	$0.00	$2.000K	$0.00
% Of Pretax Income
Net Earnings	-$13.08M	-$8.158M	-$4.423M
YoY Change	195.73%	-13.72%	-10.41%
Net Earnings / Revenue	-346.49%	-148.33%	-138.44%
Basic Earnings Per Share	-$0.02		-$0.01
Diluted Earnings Per Share	-$0.02	-$0.01	-$0.01
COMMON SHARES
Basic Shares Outstanding	558.6M	548.7M	525.4M
Diluted Shares Outstanding	575.0M		525.4M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$106.0K	$1.153M	$313.0K
YoY Change	-66.13%	86.27%	226.04%
Cash & Equivalents	$106.0K	$1.153M	$313.0K
Short-Term Investments
Other Short-Term Assets	$371.0K	$570.0K	$365.0K
YoY Change	1.64%	74.85%	-9.88%
Inventory	$1.071M	$868.0K	$1.001M
Prepaid Expenses
Receivables	$2.969M	$4.029M	$1.730M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.517M	$6.620M	$3.409M
YoY Change	32.5%	50.45%	-33.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$758.0K	$750.0K	$574.0K
YoY Change	32.06%	-32.92%	8.1%
Goodwill	$7.260M	$7.260M	$7.260M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$4.962M	$5.137M
YoY Change
Long-Term Investments
YoY Change
Other Assets		$106.0K	$106.0K
YoY Change		0.0%	-60.89%
Total Long-Term Assets	$12.98M	$13.25M	$13.61M
YoY Change	-4.59%	-6.79%	-10.0%
TOTAL ASSETS
Total Short-Term Assets	$4.517M	$6.620M	$3.409M
Total Long-Term Assets	$12.98M	$13.25M	$13.61M
Total Assets	$17.50M	$19.87M	$17.01M
YoY Change	2.84%	6.74%	-16.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.264M	$4.400M	$6.696M
YoY Change	-21.39%	-42.44%	16.9%
Accrued Expenses	$8.550M	$8.512M	$4.916M
YoY Change	73.92%	93.72%	97.27%
Deferred Revenue	$62.00K	$60.00K	$58.00K
YoY Change	6.9%	25.0%	81.25%
Short-Term Debt	$15.00M	$14.42M	$11.89M
YoY Change	26.08%		9.09%
Long-Term Debt Due	$24.57M	$24.12M	$24.66M
YoY Change	-0.39%	-4.98%	293.99%
Total Short-Term Liabilities	$70.65M	$60.19M	$53.23M
YoY Change	32.73%	6.97%	50.42%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$807.0K
YoY Change	-100.0%	-100.0%	-33.53%
Other Long-Term Liabilities	$609.0K	$668.0K	$337.0K
YoY Change	80.71%	98.22%	14.63%
Total Long-Term Liabilities	$637.0K	$696.0K	$807.0K
YoY Change	-21.07%	-47.03%	-47.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$70.65M	$60.19M	$53.23M
Total Long-Term Liabilities	$637.0K	$696.0K	$807.0K
Total Liabilities	$71.29M	$60.88M	$54.40M
YoY Change	31.04%	5.74%	47.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$207.3M	-$194.2M	-$189.1M
YoY Change	9.67%	5.6%	16.97%
Common Stock	$556.0K	$549.0K	$517.0K
YoY Change	7.54%	13.9%	7.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$53.79M	-$41.01M	-$37.40M
YoY Change
Total Liabilities & Shareholders Equity	$17.50M	$19.87M	$17.01M
YoY Change	2.84%	6.74%	-16.1%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q1
OPERATING ACTIVITIES
Net Income	-$13.08M	-$8.158M	-$4.423M
YoY Change	195.73%	-13.72%	-10.41%
Depreciation, Depletion And Amortization	$259.0K	$191.0K	$191.0K
YoY Change	35.6%	-28.2%	103.19%
Cash From Operating Activities	-$371.0K	-$3.993M	-$3.132M
YoY Change	-88.15%	-4216.49%	-6.34%
INVESTING ACTIVITIES
Capital Expenditures	$18.00K		$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$690.0K	$360.0K
YoY Change	-100.0%
Cash From Investing Activities	-$18.00K	-$690.0K	$360.0K
YoY Change	-105.0%	684.09%	-456.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-654.0K	4.720M	2.470M
YoY Change	-126.48%	1943.29%	122.12%
NET CHANGE
Cash From Operating Activities	-371.0K	-3.993M	-3.132M
Cash From Investing Activities	-18.00K	-690.0K	360.0K
Cash From Financing Activities	-654.0K	4.720M	2.470M
Net Change In Cash	-1.047M	37.00K	-302.0K
YoY Change	246.69%	-84.58%	-87.1%
FREE CASH FLOW
Cash From Operating Activities	-$371.0K	-$3.993M	-$3.132M
Capital Expenditures	$18.00K		$0.00
Free Cash Flow	-$389.0K		-$3.132M
YoY Change	-87.58%		-9.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5841000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	106000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	106000
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	16713000
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	11601000
CY2022Q4	snwv	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	7409000
CY2021Q4	snwv	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	1596000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4400000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7644000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8512000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8641000
CY2022Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	0
CY2021Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	158000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	12771000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	6883000
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	212000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4000
CY2021	snwv	Proceeds From Small Business Administration Ssba Loan ProceedsFromSmallBusinessAdministrationSSBALoan	1033000
CY2022	snwv	Proceeds From Factoring ProceedsFromFactoring	695000
CY2021	snwv	Proceeds From Factoring ProceedsFromFactoring	1737000
CY2022	snwv	Embedded Conversion Option With Issuances Of Convertible Debt EmbeddedConversionOptionWithIssuancesOfConvertibleDebt	2760000
CY2022	snwv	Warrant Issuance In Conjunction With Advances On Future Cash Receipts WarrantIssuanceInConjunctionWithAdvancesOnFutureCashReceipts	0
CY2021	snwv	Warrant Issuance In Conjunction With Advances On Future Cash Receipts WarrantIssuanceInConjunctionWithAdvancesOnFutureCashReceipts	1227000
CY2022	snwv	Warrant Issuance In Conjunction With Convertible Notes WarrantIssuanceInConjunctionWithConvertibleNotes	1708000
CY2021	snwv	Warrant Issuance In Conjunction With Convertible Notes WarrantIssuanceInConjunctionWithConvertibleNotes	1055000
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001417663
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-52985
CY2022	dei	Entity Registrant Name EntityRegistrantName	SANUWAVE Health, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1176000
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	11495 Valley View Road
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Eden Prairie
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55344
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	City Area Code CityAreaCode	770
CY2022	dei	Local Phone Number LocalPhoneNumber	419-7525
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	19300000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	558637651
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5137000
CY2022Q4	snwv	Factoring Liabilities Current FactoringLiabilitiesCurrent	2130000
CY2021Q4	snwv	Factoring Liabilities Current FactoringLiabilitiesCurrent	2183000
CY2022Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	0
CY2021Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	875000
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	230000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	293000
CY2022Q4	snwv	Operating Lease And Finance Lease Liability Noncurrent OperatingLeaseAndFinanceLeaseLiabilityNoncurrent	438000
CY2021Q4	snwv	Operating Lease And Finance Lease Liability Noncurrent OperatingLeaseAndFinanceLeaseLiabilityNoncurrent	118000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	28000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	28000
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	1361000
CY2021	snwv	Stock Issued During Period Value Reclassification Of Warrant Liability Due To Cashless Warrant Exercise StockIssuedDuringPeriodValueReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise	2030000
CY2022	snwv	Stock Issued During Period Value Cashless Warrant Exercises StockIssuedDuringPeriodValueCashlessWarrantExercises	2166000
CY2022	snwv	Stock Issued During Period Warrants Exercised Value StockIssuedDuringPeriodWarrantsExercisedValue	100000
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3720000
CY2022	snwv	Shares Issued For Settlement Of Debt And Warrants SharesIssuedForSettlementOfDebtAndWarrants	1361000
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	888000
CY2022	snwv	Proceeds From Small Business Administration Ssba Loan ProceedsFromSmallBusinessAdministrationSSBALoan	0
CY2022	snwv	Reclassification Of Warrant Liability Due To Cashless Warrant Exercise ReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise	2166000
CY2021	snwv	Reclassification Of Warrant Liability Due To Cashless Warrant Exercise ReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise	2030000
CY2022	snwv	Settlement Of Debt And Warrants With Stock SettlementOfDebtAndWarrantsWithStock	1361000
CY2021	snwv	Settlement Of Debt And Warrants With Stock SettlementOfDebtAndWarrantsWithStock	0
CY2022	snwv	Working Capital Balances Refinanced Into Convertible Promissory Notes WorkingCapitalBalancesRefinancedIntoConvertiblePromissoryNotes	2363000
CY2021	snwv	Working Capital Balances Refinanced Into Convertible Promissory Notes WorkingCapitalBalancesRefinancedIntoConvertiblePromissoryNotes	0
CY2021	snwv	Embedded Conversion Option With Issuances Of Convertible Debt EmbeddedConversionOptionWithIssuancesOfConvertibleDebt	4138000
CY2022	snwv	Common Shares Issued In Conjunction With Senior Secured Debt CommonSharesIssuedInConjunctionWithSeniorSecuredDebt	3720000
CY2021	snwv	Common Shares Issued In Conjunction With Senior Secured Debt CommonSharesIssuedInConjunctionWithSeniorSecuredDebt	0
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6825000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	984000
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y9M18D
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	704000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	704000
CY2022	snwv	Initial Warranty Period Of Device Product InitialWarrantyPeriodOfDeviceProduct	P1Y
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	324000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	377000
CY2022	snwv	Class Of Warrant Or Right Exercise Price ClassOfWarrantOrRightExercisePrice	0.01
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	549471000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	518356000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1811193000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	290332000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	570000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	343000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	641000
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	931000
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	343000
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	234000
CY2022Q4	us-gaap	Inventory Net InventoryNet	868000
CY2021Q4	us-gaap	Inventory Net InventoryNet	1040000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6825000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1688000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	704000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	704000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	704000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	704000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	487000
CY2022Q4	snwv	Accrued Registration Penalties Current AccruedRegistrationPenaltiesCurrent	1583000
CY2021Q4	snwv	Accrued Registration Penalties Current AccruedRegistrationPenaltiesCurrent	1950000
CY2022Q4	snwv	Accrued License Fees Current AccruedLicenseFeesCurrent	892000
CY2021Q4	snwv	Accrued License Fees Current AccruedLicenseFeesCurrent	893000
CY2022Q4	snwv	Accrued Board Of Director Fees Current AccruedBoardOfDirectorFeesCurrent	415000
CY2021Q4	snwv	Accrued Board Of Director Fees Current AccruedBoardOfDirectorFeesCurrent	507000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4585000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4247000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1037000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1044000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8512000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8641000
CY2021Q4	snwv	Convertible Promissory Notes And Convertible Promissory Note Related Parties Current ConvertiblePromissoryNotesAndConvertiblePromissoryNoteRelatedPartiesCurrent	13197000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000
CY2022Q4	snwv	Accounts Receivable Transferred AccountsReceivableTransferred	-2564000
CY2021Q4	snwv	Accounts Receivable Transferred AccountsReceivableTransferred	-2026000
CY2022Q4	snwv	Accounts Receivable Reserve Amount AccountsReceivableReserveAmount	434000
CY2021Q4	snwv	Accounts Receivable Reserve Amount AccountsReceivableReserveAmount	289000
CY2022Q4	snwv	Funds Due To Factoring FundsDueToFactoring	-2130000
CY2021Q4	snwv	Funds Due To Factoring FundsDueToFactoring	-1737000
CY2022Q4	snwv	Advances On Future Cash Receipts AdvancesOnFutureCashReceipts	0
CY2021Q4	snwv	Advances On Future Cash Receipts AdvancesOnFutureCashReceipts	446000
CY2022Q4	snwv	Factoring Liabilities Current FactoringLiabilitiesCurrent	2130000
CY2021Q4	snwv	Factoring Liabilities Current FactoringLiabilitiesCurrent	2183000
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	25548000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3766000
CY2022Q4	snwv	Debt Instrument Conversion Option DebtInstrumentConversionOption	2340000
CY2022Q4	snwv	Convertible Promissory Notes And Convertible Promissory Note Related Parties Current ConvertiblePromissoryNotesAndConvertiblePromissoryNoteRelatedPartiesCurrent	24122000
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	8042000
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1100000
CY2021Q4	snwv	Debt Instrument Conversion Option DebtInstrumentConversionOption	6255000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-253000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-32000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	341000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	69000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-253000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-32000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	290000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	341000
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	190357000
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.19
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y5M4D
CY2021	snwv	Class Of Warrant Or Right Issuances In Period ClassOfWarrantOrRightIssuancesInPeriod	25926000
CY2021	snwv	Class Of Warrant Or Right Weighted Average Exercise Price Of Issuances ClassOfWarrantOrRightWeightedAverageExercisePriceOfIssuances	0.18
CY2021	snwv	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	11400000
CY2021	snwv	Class Of Warrant Or Right Weighted Average Exercise Price Of Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfExercised	0.01
CY2021	snwv	Class Of Warrant Or Right Forfeited Or Expired In Period ClassOfWarrantOrRightForfeitedOrExpiredInPeriod	0
CY2021	snwv	Class Of Warrant Or Right Weighted Average Exercise Price Of Forfeited Or Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfForfeitedOrExpired	0
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	204883000
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.2
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y6M14D
CY2022	snwv	Class Of Warrant Or Right Issuances In Period ClassOfWarrantOrRightIssuancesInPeriod	1031276000
CY2022	snwv	Class Of Warrant Or Right Weighted Average Exercise Price Of Issuances ClassOfWarrantOrRightWeightedAverageExercisePriceOfIssuances	0.06
CY2022	snwv	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	27943000
CY2022	snwv	Class Of Warrant Or Right Weighted Average Exercise Price Of Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfExercised	0.09
CY2022	snwv	Class Of Warrant Or Right Forfeited Or Expired In Period ClassOfWarrantOrRightForfeitedOrExpiredInPeriod	0
CY2022	snwv	Class Of Warrant Or Right Weighted Average Exercise Price Of Forfeited Or Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfForfeitedOrExpired	0
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1208216000
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.07
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M18D
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2500000000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	28000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	28000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5657000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15511000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11383000
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1231000
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1627000
CY2022	us-gaap	Revenues Revenues	16742000
CY2021	us-gaap	Revenues Revenues	13010000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-10279000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-27208000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-12000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-23000
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-10291000
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-27231000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5038000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	753000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-869000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	4000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-4905000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-5903000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2021Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	0
CY2022Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2161000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5718000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-473000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-837000
CY2022	snwv	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsAmount	-3270000
CY2021	snwv	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsAmount	417000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4905000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5903000
CY2022	snwv	Income Tax Reconciliation Registration Penalties IncomeTaxReconciliationRegistrationPenalties	67000
CY2021	snwv	Income Tax Reconciliation Registration Penalties IncomeTaxReconciliationRegistrationPenalties	354000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	934000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-91000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	38323000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33238000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	24000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	23000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	9000
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	14000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1325000
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1622000
CY2022Q4	snwv	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	150000
CY2021Q4	snwv	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	96000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1487000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1613000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	750000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	698000
CY2022Q4	snwv	Deferred Tax Assets Tax Deferred Expense Equity Cost DeferredTaxAssetsTaxDeferredExpenseEquityCost	0
CY2021Q4	snwv	Deferred Tax Assets Tax Deferred Expense Equity Cost DeferredTaxAssetsTaxDeferredExpenseEquityCost	49000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	116000
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	1031000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	898000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	43215000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	38251000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	43070000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	38165000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	145000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	86000
CY2022Q4	snwv	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	145000
CY2021Q4	snwv	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	86000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	145000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	86000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0
CY2022Q4	snwv	Capitalized Research And Development Costs Section174 CapitalizedResearchAndDevelopmentCostsSection174	600000
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0
CY2022	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	143000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	128000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	85000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	128000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	82000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	78000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	82000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	55000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	447000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	334000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	313000
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	785000
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1730000
CY2022Q1	us-gaap	Inventory Net InventoryNet	1001000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	365000
CY2022Q1	us-gaap	Assets Current AssetsCurrent	3409000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	315000
CY2022Q1	snwv	Operating Lease And Finance Lease Right Of Use Asset After Accumulated Amortization OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization	259000
CY2022Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5665000
CY2022Q1	us-gaap	Goodwill Goodwill	7260000
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	106000
CY2022Q1	us-gaap	Assets Assets	17014000
CY2022Q1	us-gaap	Senior Notes Current SeniorNotesCurrent	11894000
CY2022Q1	snwv	Convertible Promissory Notes Payable Current ConvertiblePromissoryNotesPayableCurrent	10532000
CY2022Q1	snwv	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	1596000
CY2022Q1	snwv	Advances On Future Cash Receipts AdvancesOnFutureCashReceipts	416000
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6760000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5470000
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3623000
CY2022Q1	snwv	Due Under Factoring Agreement Current DueUnderFactoringAgreementCurrent	1231000
CY2022Q1	snwv	Warrant Liability Current WarrantLiabilityCurrent	8300000
CY2022Q1	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	226000
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	3132000
CY2022Q1	snwv	Accrued Interest Payable Related Parties Current AccruedInterestPayableRelatedPartiesCurrent	345000
CY2022Q1	snwv	Operating Lease And Finance Lease Liability Current OperatingLeaseAndFinanceLeaseLiabilityCurrent	268000
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	58000
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	58000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	53909000
CY2022Q1	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	807000
CY2022Q1	snwv	Operating Lease And Finance Lease Liability Noncurrent OperatingLeaseAndFinanceLeaseLiabilityNoncurrent	34000
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	303000
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	28000
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1172000
CY2022Q1	us-gaap	Liabilities Liabilities	55081000
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	517000
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	150533000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-189050000
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-67000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-38067000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17014000
CY2022Q1	us-gaap	Revenues Revenues	3195000
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	889000
CY2022Q1	us-gaap	Gross Profit GrossProfit	2306000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2205000
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1715000
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	166000
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	176000
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4262000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1956000
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3136000
CY2022Q1	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	56000
CY2022Q1	snwv	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	-3482000
CY2022Q1	snwv	Loss On Issuance Of Debt LossOnIssuanceOfDebt	3434000
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1000
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3145000
CY2022Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-5101000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5101000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5101000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	525414534
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	525414534
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5101000
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	176000
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15000
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3482000
CY2022Q1	snwv	Loss On Issuance Of Debt LossOnIssuanceOfDebt	3434000
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	889000
CY2022Q1	us-gaap	Financing Receivable Accrued Interest Writeoff FinancingReceivableAccruedInterestWriteoff	611000
CY2022Q1	snwv	Interest Payable Related Parties InterestPayableRelatedParties	56000
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	804000
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-39000
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	39000
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-43000
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-866000
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	993000
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-549000
CY2022Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-155000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3132000
CY2022Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-360000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	360000
CY2022Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	2940000
CY2022Q1	snwv	Payments For Factoring PaymentsForFactoring	505000
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	100000
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	65000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2470000
CY2022Q1	snwv	Reclassification Of Warrant Liability Due To Cashless Warrant Exercise ReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise	2167000
CY2022Q1	snwv	Warrants Issued In Conjunction With Senior Secured Promissory Note Payable WarrantsIssuedInConjunctionWithSeniorSecuredPromissoryNotePayable	2654000
CY2022Q1	snwv	Common Shares Issued In Conjunction With Senior Secured Promissory Note Payable CommonSharesIssuedInConjunctionWithSeniorSecuredPromissoryNotePayable	3720000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1484000
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	800000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1749000
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-306000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	619000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	313000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	574000
CY2022Q2	us-gaap	Inventory Net InventoryNet	925000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	400000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	4558000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	535000
CY2022Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5489000
CY2022Q2	us-gaap	Goodwill Goodwill	7260000
CY2022Q2	us-gaap	Assets Assets	17842000
CY2022Q2	us-gaap	Senior Notes Current SeniorNotesCurrent	12334000
CY2022Q2	snwv	Convertible Promissory Notes Payable Current ConvertiblePromissoryNotesPayableCurrent	6523000
CY2022Q2	snwv	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	1596000
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1484000
CY2022Q2	snwv	Advances On Future Cash Receipts AdvancesOnFutureCashReceipts	398000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	7159000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6641000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4264000
CY2022Q2	snwv	Due Under Factoring Agreement Current DueUnderFactoringAgreementCurrent	1792000
CY2022Q2	snwv	Warrant Liability Current WarrantLiabilityCurrent	5295000
CY2022Q2	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	272000
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	3737000
CY2022Q2	snwv	Accrued Interest Payable Related Parties Current AccruedInterestPayableRelatedPartiesCurrent	402000
CY2022Q2	snwv	Operating Lease And Finance Lease Liability Current OperatingLeaseAndFinanceLeaseLiabilityCurrent	185000
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	64000
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	107000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	52253000
CY2022Q2	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	761000
CY2022Q2	snwv	Operating Lease And Finance Lease Liability Noncurrent OperatingLeaseAndFinanceLeaseLiabilityNoncurrent	40000
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	295000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	28000
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1124000
CY2022Q2	us-gaap	Liabilities Liabilities	53377000
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	529000
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	151409000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-187406000
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-67000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-35535000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17842000
CY2022Q2	us-gaap	Revenues Revenues	3882000
	us-gaap	Revenues Revenues	7077000
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1096000
	us-gaap	Cost Of Revenue CostOfRevenue	1986000
CY2022Q2	us-gaap	Gross Profit GrossProfit	2786000
	us-gaap	Gross Profit GrossProfit	5091000
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3730000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5935000
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1672000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3387000
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	171000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	337000
CY2022Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-51000
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-51000
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	210000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	386000
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	5834000
	us-gaap	Operating Expenses OperatingExpenses	10096000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3048000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5005000
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	2903000
	us-gaap	Interest Expense Debt InterestExpenseDebt	6040000
CY2022Q2	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	56000
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	112000
CY2022Q2	snwv	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	-7861000
	snwv	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	-11343000
CY2022Q2	snwv	Loss On Issuance Of Debt LossOnIssuanceOfDebt	0
	snwv	Loss On Issuance Of Debt LossOnIssuanceOfDebt	3434000
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-211000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-211000
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2000
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4693000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1548000
CY2022Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1645000
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3457000
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1645000
	us-gaap	Net Income Loss NetIncomeLoss	-3457000
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1645000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3457000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	538560051
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	532589825
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	871984091
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	532589825
	us-gaap	Net Income Loss NetIncomeLoss	-3457000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	352000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	52000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	888000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-211000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11343000
	snwv	Loss On Issuance Of Debt LossOnIssuanceOfDebt	3434000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1304000
	us-gaap	Financing Receivable Accrued Interest Writeoff FinancingReceivableAccruedInterestWriteoff	1215000
	snwv	Interest Payable Related Parties InterestPayableRelatedParties	112000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	733000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-115000
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	74000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-47000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-486000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1607000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	103000
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-108000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5201000
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	948000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	948000
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	2940000
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2130000
	snwv	Proceeds From Factoring ProceedsFromFactoring	55000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	100000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	121000
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5104000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	865000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	619000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1484000
	us-gaap	Interest Paid Net InterestPaidNet	2045000
	snwv	Reclassification Of Warrant Liability Due To Cashless Warrant Exercise ReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise	2167000
	snwv	Warrants Issued In Conjunction With Senior Secured Promissory Note Payable WarrantsIssuedInConjunctionWithSeniorSecuredPromissoryNotePayable	2654000
	snwv	Common Shares Issued In Conjunction With Senior Secured Promissory Note Payable CommonSharesIssuedInConjunctionWithSeniorSecuredPromissoryNotePayable	3720000
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1112000
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	800000
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2403000
CY2022Q3	us-gaap	Inventory Net InventoryNet	862000
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1154000
CY2022Q3	us-gaap	Assets Current AssetsCurrent	5531000
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	673000
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5313000
CY2022Q3	us-gaap	Goodwill Goodwill	7260000
CY2022Q3	us-gaap	Assets Assets	18777000
CY2022Q3	us-gaap	Senior Notes Current SeniorNotesCurrent	12773000
CY2022Q3	snwv	Convertible Promissory Notes Payable Current ConvertiblePromissoryNotesPayableCurrent	13174000
CY2022Q3	snwv	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	5858000
CY2022Q3	snwv	Advances On Future Cash Receipts AdvancesOnFutureCashReceipts	194000
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5225000
	snwv	Loss On Issuance Of Debt LossOnIssuanceOfDebt	3434000
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4841000
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3792000
CY2022Q3	snwv	Due Under Factoring Agreement Current DueUnderFactoringAgreementCurrent	1510000
CY2022Q3	snwv	Warrant Liability Current WarrantLiabilityCurrent	1196000
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	4206000
CY2022Q3	snwv	Accrued Interest Payable Related Parties Current AccruedInterestPayableRelatedPartiesCurrent	546000
CY2022Q3	snwv	Operating Lease And Contract Lease Liability Current OperatingLeaseAndContractLeaseLiabilityCurrent	249000
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	30000
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	53594000
CY2022Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	0
CY2022Q3	snwv	Operating Lease And Finance Lease Liability Noncurrent OperatingLeaseAndFinanceLeaseLiabilityNoncurrent	263000
CY2022Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	205000
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	28000
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	496000
CY2022Q3	us-gaap	Liabilities Liabilities	54090000
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	549000
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	152750000
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188545000
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-67000
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-35313000
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18777000
CY2022Q3	us-gaap	Revenues Revenues	4166000
	us-gaap	Revenues Revenues	11242000
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	1157000
	us-gaap	Cost Of Revenue CostOfRevenue	3141000
CY2022Q3	us-gaap	Gross Profit GrossProfit	3009000
	us-gaap	Gross Profit GrossProfit	8101000
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3498000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9433000
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1650000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5037000
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	157000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	494000
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-51000
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	189000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	575000
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5494000
	us-gaap	Operating Expenses OperatingExpenses	15590000
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2485000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7489000
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3382000
	us-gaap	Interest Expense Debt InterestExpenseDebt	9421000
CY2022Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	439000
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	551000
CY2022Q3	snwv	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	-5252000
	snwv	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	-16597000
CY2022Q3	snwv	Loss On Issuance Of Debt LossOnIssuanceOfDebt	0
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-86000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-297000
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1000
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2981000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1000
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1346000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2893000
CY2022Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1139000
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-4596000
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1139000
	us-gaap	Net Income Loss NetIncomeLoss	-4596000
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1139000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4596000
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	561069625
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	561069625
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	542484779
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	542484779
	us-gaap	Net Income Loss NetIncomeLoss	-4596000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	681000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	62000
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	888000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-297000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-51000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-16597000
	snwv	Loss On Issuance Of Debt LossOnIssuanceOfDebt	3434000
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2998000
	us-gaap	Financing Receivable Accrued Interest Writeoff FinancingReceivableAccruedInterestWriteoff	1836000
	snwv	Interest Payable Related Parties InterestPayableRelatedParties	168000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	69000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-178000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-656000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1693000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	271000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-473000
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-94000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13176000
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-1022000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1022000
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	2940000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	12366000
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	640000
	snwv	Payments For Factoring PaymentsForFactoring	227000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	100000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	174000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12664000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-17000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	493000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	619000
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1112000
	us-gaap	Interest Paid Net InterestPaidNet	3345000
	snwv	Reclassification Of Warrant Liability Due To Cashless Warrant Exercise ReclassificationOfWarrantLiabilityDueToCashlessWarrantExercise	2166000
	snwv	Settlement Of Debt And Warrants With Stock SettlementOfDebtAndWarrantsWithStock	1361000
	snwv	Warrants Issued In Conjunction With Senior Secured Promissory Note Payable WarrantsIssuedInConjunctionWithSeniorSecuredPromissoryNotePayable	2654000
	snwv	Common Shares Issued In Conjunction With Senior Secured Promissory Note Payable CommonSharesIssuedInConjunctionWithSeniorSecuredPromissoryNotePayable	3720000
	snwv	Embedded Conversion Option With Issuances Of Convertible Debt EmbeddedConversionOptionWithIssuancesOfConvertibleDebt	2309000
	snwv	Working Capital Balances Refinanced Into Convertible Notes Payable WorkingCapitalBalancesRefinancedIntoConvertibleNotesPayable	2273000
	snwv	Warrant Issuance In Conjunction With Convertible Notes WarrantIssuanceInConjunctionWithConvertibleNotes	1463000

Files In Submission

Name	View Source	Status
snwv-20221231_cal.xml	Edgar Link	unprocessable
0001140361-23-015331-index-headers.html	Edgar Link	pending
0001140361-23-015331-index.html	Edgar Link	pending
0001140361-23-015331.txt	Edgar Link	pending
0001140361-23-015331-xbrl.zip	Edgar Link	pending
brhc10050349_10k.htm	Edgar Link	pending
brhc10050349_ex21-1.htm	Edgar Link	pending
brhc10050349_ex23-1.htm	Edgar Link	pending
brhc10050349_ex31-1.htm	Edgar Link	pending
brhc10050349_ex31-2.htm	Edgar Link	pending
brhc10050349_ex32-1.htm	Edgar Link	pending
brhc10050349_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
brhc10050349_10k_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
snwv-20221231.xsd	Edgar Link	pending
snwv-20221231_def.xml	Edgar Link	unprocessable
snwv-20221231_lab.xml	Edgar Link	unprocessable
snwv-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SNWV
SANUWAVE Health, Inc. Stock $snwv

2023 Q1 Form 10-K Financial Statement

#000114036123015331 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SNWV SANUWAVE Health, Inc. Stock $snwv

2023 Q1 Form 10-K Financial Statement

#000114036123015331 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SNWV
SANUWAVE Health, Inc. Stock $snwv